Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Older adults
2021
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(130)
Topics
Regions
Americas
(1)
Europe
(1)
Western Pacific
(3)
Countries
Australia
(1)
Canada
(1)
China
(1)
Japan
(1)
United Kingdom
(1)
Diseases
COVID-19
(106)
Diphtheria
(1)
Ebola
(1)
Hepatitis B
(3)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(8)
Pertussis
(1)
Pneumococcal disease
(2)
Tetanus
(1)
Tick-borne encephalitis
(1)
Publication date
2021
(131)
2024
(1)
2023
(61)
2022
(226)
2020
(73)
2019
(17)
2018
(19)
2017
(19)
2016
(15)
2015
(12)
2014
(10)
2013
(7)
2012
(9)
2011
(3)
Target population
Older adults
(131)
Adolescents
(67)
Adults
(174)
All age groups
(173)
Children
(46)
Healthcare workers
(40)
Newborn
(30)
Parents/caregivers
(18)
Pregnant women
(39)
Risk group
(2)
Travellers
(1)
Available to download in languages
English (EN)
(1)
131 results found
2021
∙
Colrat, F. Thommes, E. Largeron, N. Alvarez, F. P.
Economic evaluation of high-dose inactivated influenza vaccine in adults aged >=65 years: A systematic literature review
2021
∙
Coleman, B. L. Sanderson, R. Haag, M. D. M. McGovern, I.
Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis
2021
∙
Cheng, C. J. Lu, C. Y. Chang, Y. H. Sun, Y. Chu, H. J. Lee, C. Y. Liu, C. H. Lin, C. H. Lu, C. J. Li, C. Y.
Effectiveness of the who-authorized covid-19 vaccines: A rapid review of global reports till 30 june 2021
2021
∙
Lee, J. K. H. Lam, G. K. L. Shin, T. Samson, S. I. Greenberg, D. P. Chit, A.
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis
2021
∙
Khan, M. Li, X. Yan, M. Li, Z. Yang, H. Liao, G.
Efficacy and safety of actively personalized neoantigen vaccination in the management of newly diagnosed glioblastoma: A systematic review
2021
∙
Cheng, H. Peng, Z. Luo, W. Si, S. Mo, M. Zhou, H. Xin, X. Liu, H. Yu, Y.
Efficacy and safety of covid-19 vaccines in phase iii trials: A meta-analysis
2021
∙
Pormohammad, A. Zarei, M. Ghorbani, S. Mohammadi, M. Razizadeh, M. H. Turner, D. L. Turner, R. J.
Efficacy and safety of covid-19 vaccines: A systematic review and meta-analysis of randomized clinical trials
2021
∙
Kumar, S. Saurabh, M. K. Maharshi, V.
Efficacy and safety of potential vaccine candidates against coronavirus disease 2019: A systematic review
2021
∙
Sharif, N. Alzahrani, K. J. Ahmed, S. N. Dey, S. K.
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
2021
∙
Taniguchi, K. Ikeda, S. Hagiwara, Y. Tsuzuki, D. Klai, M. Sakai, Y. Crawford, B. Nealon, J.
Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta-analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register